✦ LIBER ✦
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma
✍ Scribed by Gupta, A.; Love, S.; Schuh, A.; Shanyinde, M.; Larkin, J. M.; Plummer, R.; Nathan, P. D.; Danson, S.; Ottensmeier, C. H.; Lorigan, P.; Collins, L.; Wise, A.; Asher, R.; Lisle, R.; Middleton, M. R.
- Book ID
- 121827137
- Publisher
- Oxford University Press
- Year
- 2014
- Tongue
- English
- Weight
- 202 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0923-7534
No coin nor oath required. For personal study only.